It is acknowledged that prostate cancer occurs predominantly in elderly patients, with peak incidence occurring between the ages of 70 and 74 years (Klein et al., 2007). Nevertheless, studies have documented an ag
Background: In the general population, prostate adenocarcinoma affects predominately older men. If f...
Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in ...
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for m...
It’s the most common cancer among men. Prostate cancer will affect one in five men at some point in ...
grantor: University of TorontoPrevious studies have demonstrated large age-based variation...
There is significant controversy on how aggressively to treat older men with prostate cancer. We ide...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...
Objective To assess, in a meta-analysis of published studies, whether age influences the behaviour ...
Objectives: To examine the clinical features, applied treatments, and survival of older patients wit...
Based on the exponential aging of the population and the increasing life expectancy in industrialize...
PURPOSE: To discuss the issue of screening for prostate cancer in elderly individuals. The impact of...
Background & aims. Based on autopsy finding that many elderly men bear clinically-insignificant pros...
Purpose: To test the effect of age on cancer-specific mortality (CSM) in most contemporary prostate ...
Purpose of reviewWith the pervasive use of prostate-specific antigen-based screening, many men in th...
Given the demographic trends toward a considerably longer life expectancy, the percentage of elderly...
Background: In the general population, prostate adenocarcinoma affects predominately older men. If f...
Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in ...
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for m...
It’s the most common cancer among men. Prostate cancer will affect one in five men at some point in ...
grantor: University of TorontoPrevious studies have demonstrated large age-based variation...
There is significant controversy on how aggressively to treat older men with prostate cancer. We ide...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...
Objective To assess, in a meta-analysis of published studies, whether age influences the behaviour ...
Objectives: To examine the clinical features, applied treatments, and survival of older patients wit...
Based on the exponential aging of the population and the increasing life expectancy in industrialize...
PURPOSE: To discuss the issue of screening for prostate cancer in elderly individuals. The impact of...
Background & aims. Based on autopsy finding that many elderly men bear clinically-insignificant pros...
Purpose: To test the effect of age on cancer-specific mortality (CSM) in most contemporary prostate ...
Purpose of reviewWith the pervasive use of prostate-specific antigen-based screening, many men in th...
Given the demographic trends toward a considerably longer life expectancy, the percentage of elderly...
Background: In the general population, prostate adenocarcinoma affects predominately older men. If f...
Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in ...
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for m...